2 Finanzierungen - 6.304€

daten seit 2019 verfügbar

2020

  1. Evaluation of the anti-CD160 antibodies in in vivo models.

    euro 5.000,00

2019

  1. Evaluation of anti-CD160 antibodies in "in vivo" models.

    euro 1.304,35